Community-driven HPV prevention for mothers and daughters in Nigeria
Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV)
This project uses community ideas to boost HPV vaccination for girls 9–26 and home HPV self-testing for women 30–49 in Nigeria by engaging mothers and daughters.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11179304 on NIH RePORTER |
What this research studies
If you are a mother or daughter in Nigeria, the team will invite you to help create locally relevant messages and ways to share information about HPV vaccination and self-testing. They will run open calls and community workshops to crowdsource messages and materials from residents, then choose and adapt the best entries for local outreach. Those community-designed messages will be used to encourage vaccine uptake among girls 9–26 and HPV self-collection screening among women 30–49. Local partners and leaders will help deliver the outreach so materials fit cultural norms and local health services.
Who could benefit from this research
Good fit: Ideal participants are mother-daughter pairs in Nigerian communities with daughters aged about 9–26 and mothers or female caregivers, and women aged 30–49 eligible for HPV self-collection screening.
Not a fit: People who live outside the Nigerian study communities, are outside the target age ranges, or are not part of mother-daughter pairs are unlikely to receive direct benefits from this project.
Why it matters
Potential benefit: If successful, this work could increase HPV vaccination and screening in participating communities and help lower cervical cancer risk over time.
How similar studies have performed: HPV vaccination and self-collection are proven ways to reduce cervical cancer risk, and crowdsourcing for health messaging has shown promise but is relatively new in this specific mother-daughter, Nigerian context.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.